We are now two standalone organizations
Life Sciences & Diagnostics and Analytical & Enterprise Solutions
A Life Sciences and Diagnostics business focused on enabling scientists and healthcare professionals to advance research, discovery and detection to improve global health
An Analytical and Enterprise solutions business, including leading OneSource laboratory services, focused on accelerating scientific outcomes
IVISbrite™ D-Luciferin Bioluminescent Substrate in RediJect™ Solution (RediJect D-Luciferin K+ salt) is a bioluminescent in vivo substrate in a convenient ready-to-use, pre-formulated injectable format developed by 爱游戏平台注册登录 to fit your laboratory workflow.
For research use only. Not for use in diagnostic procedures.
true falsePlease enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
With 爱游戏平台注册登录 ’s IVISbrite D-Luciferin Bioluminescent Substrate in RediJect Solution you can ensure a reproducible result by minimizing variability in formulation, minimizing freeze/thaw and controlling batch to batch variation. With thousands of publications and millions of mice imaged, we have formulated its substrates to fit common workflow patterns and optimize results. You are free to concentrate on animal handling and biology.
Luciferase Classification | Firefly |
---|---|
Product Brand Name | IVISbrite |
Quantity in a Package Amount | 1.0 Units |
Shipping Condition | Dry Ice |
Type | Luciferin |
Unit Size | 10 vials |
Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...